Table 3.
Preoperative imaging staging among patients who could avoid it.
| Gleason ≤ 6; PSA ≤ 20 (n = 1063) | Gleason 7; PSA ≤ 20 (415) | Gleason ≤ 7; PSA ≤ 20 (1478) | |
|---|---|---|---|
| T-staging: | 567 (53.34%) | 238 (57.35%) | 805 (54.76%) |
| CT | 514 (90.8%) | 213 (89.50%) | 727 (90.31%) |
| eMRI | 26 (4.5%) | 8 (3.36%) | 34 (4.22%) |
| MRI | 26 (4.5%) | 14 (5.88%) | 40 (4.97%) |
| CT+MRI | 1 (0.2%) | 1 (0.42%) | 2 (0.25%) |
| CT+eMRI | 0 | 1 (0.42%) | 1 (0.12%) |
| MRI+eMRI | 0 | 1 (0.42%) | 1 (0.12%) |
| N-staging: | 545 (51.27%) | 244 (58.80%) | 789 (53.67%) |
| CT | 499 (91.5%) | 209 (85.66%) | 708 (89.73%) |
| MRI | 25 (4.6%) | 14 (5.74%) | 39 (4.94%) |
| PET | 20 (3.7%) | 14 (5.74%) | 34 (4.31%) |
| CT+PET | 1 (0.2%) | 5 (2.04%) | 6 (0.76%) |
| MRI+PET | 0 | 1 (0.41%) | 1 (0.13%) |
| CT+MRI | 0 | 1 (0.41%) | 1 (0.13%) |
| M-staging: | 757 (71.21%) | 322 (77.60%) | 1079 (73.40%) |
| Bone scan | 757 (100%) | 100% | 100% |